Circulating Growth Differentiation Factor 15 and Preeclampsia: A Meta-Analysis
Hormone and Metabolic Research · 01.02.2023 · 55 (02) · 114-123
DOI: 10.1055/a-1956-2961 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.02.2023. Verfasst von Lihong Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Baogang Hospital, Baotou, China. Hauptthemen laut MEDLINE: Pre-Eclampsia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Growth differentiation factor 15 (GDF-15) has been suggested as a potential biomarker of preeclampsia. However, previous studies evaluating circulating GDF-15 in women with preeclampsia showed inconsistent results. A meta-analysis was performed accordingly in this study. Observational studies comparing circulating GDF-15 between women with preeclampsia normal pregnancy were identified by search of electronic databases including PubMed, Embase, Web of Science, Wanfang, and CNKI. The Newcastle-Ottawa Scale (NOS) was used for assessing the quality of the studies. A randomized-effect model incorporating the possible between-study heterogeneity was used to pool the results. Eleven observational studies including 498 women with preeclampsia and 2349 women with normal pregnancy contributed to the meta-analysis. Results showed that compared to controls of women with normal pregnancy at least matched for gestational ages, women with preeclampsia had significantly higher circulating GDF-15 at the diagnosis [standard mean difference (SMD): 0.66, 95% confidence interval (CI): 0.16 to 1.17, p=0.01, I2=93%]. Subgroup analysis showed consistent results in women with preterm and term preeclampsia in Asian and non-Asian women and in studies with different quality scores, which were not statistically significant between subgroups (p for subgroup difference>0.05). Moreover, a higher level of GDF-15 was also found before the diagnosis in women who subsequently developed preeclampsia than those who did not (SMD: 1.32, 95% CI: 0.45 to 2.18, p=0.003, I2=89%). In conclusion, a higher circulating GDF-15 is observed in women with preeclampsia even before the diagnosis of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Baogang Hospital, Baotou, China.
Zitieren
APA
Wang, L., & Yang, Q. (2023). Circulating Growth Differentiation Factor 15 and Preeclampsia: A Meta-Analysis. Hormone and Metabolic Research, 55(02), 114-123. https://doi.org/10.1055/a-1956-2961
Vancouver
Wang L, Yang Q. Circulating Growth Differentiation Factor 15 and Preeclampsia: A Meta-Analysis. Hormone and Metabolic Research. 2023;55(02):114-123. doi:10.1055/a-1956-2961
BibTeX
@article{Wang2023,
author = {Wang, Lihong and Yang, Qiuli},
title = {Circulating Growth Differentiation Factor 15 and Preeclampsia: A Meta-Analysis},
journal = {Hormone and Metabolic Research},
year = {2023},
volume = {55},
number = {02},
pages = {114--123},
doi = {10.1055/a-1956-2961}
}
EUVIMED